Trial intelligence / Profile preview

Dl-3-n-butylphthalide vs Cerebrolysin in Acute Ischemic Stroke

NCT02149875Phase 2Completed

Sponsor
Shanghai Sixth People's Hospital
Start
Jan 2010
Primary completion
May 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of butylphthalide in ischemic stroke, sponsored by Shanghai Sixth People's Hospital. Started Jan 2010; status: completed.

02

Drugs

butylphthalide
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT02149875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02149875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call